In comeback bid, Shkreli’s old company gets OK to buy life-saving drug | Ars Technica


Amid outcry, KaloBios may jack the drug’s price and make millions off FDA voucher.

Source: In comeback bid, Shkreli’s old company gets OK to buy life-saving drug | Ars Technica

Leave a Reply

Your email address will not be published. Required fields are marked *

4 × three =

This site uses Akismet to reduce spam. Learn how your comment data is processed.